DETECT CARDIOVASCULAR RISK EARLIER
Advanced Blood Testing for Heart & Metabolic Health
An advanced blood test goes beyond standard labs (like basic cholesterol or glucose) to uncover how and why disease develops—often years before symptoms appear. Instead of just measuring totals, it analyzes particle size, inflammation, metabolic function, and genetic risk markers.
The benefit is simple but powerful: earlier detection, more precise risk assessment, and more personalized treatment. It helps clinicians move from reactive care (treating disease) to proactive care (preventing it).
A Complete Picture of Your Heart Health
An advanced blood test combines these markers to give a 360-degree view of cardiovascular and metabolic health:
- Particle risk → ApoB, NMR LipoProfile
- Inflammation → GlycA, hs-CRP, Lp-PLA2
- Genetic risk → Lp(a)
- Metabolic health → Diabetes Risk Index
Bottom line:
It allows providers to detect risk earlier, personalize treatment more precisely, and help patients prevent serious conditions, before they show up on standard lab tests or develop into noticeable symptoms.
Key Cardiometabolic Panels Explained
Advanced blood testing is designed to go beyond surface-level results and uncover the underlying drivers of cardiovascular and metabolic health. The panel below offers a unique lens, whether it’s identifying hidden inflammation, measuring true particle risk, or detecting early metabolic dysfunction.
- ApoB (Apolipoprotein B): Measures the number of atherogenic (plaque-causing) particles (LDL, VLDL, IDL) in your blood. Each LDL particle carries one ApoB protein, so this test reflects the true number of particles that can enter artery walls. You can have “normal” LDL cholesterol but still have high ApoB, meaning higher cardiovascular risk. ApoB is a key biomarker and better predictor of heart disease risk than the standard LDL cholesterol test alone.
- Diabetes Risk Index (DRI): Detects early signs of insulin resistance and metabolic dysfunction. It identifies an individual's risk for developing prediabetes and type 2 diabetes by analyzing specific biomarkers, assisting in earlier lifestyle or medical intervention.
- GlycA (Glycoprotein Acetylation): Measures chronic, systemic inflammation and predicts future risk of cardiovascular disease (CVD), type 2 diabetes, and severe infections. GlycA is a more stable, reliable marker, often capturing risk that traditional inflammatory markers miss.
- hs-CRP (High-Sensitivity C-Reactive Protein): Measures tiny, precise amounts of CRP, a protein produced by the liver, to detect low levels of inflammation in the body. It is primarily used to assess the long-term risk of cardiovascular disease, such as heart attacks, strokes, and peripheral artery disease (PAD) primary caused by atherosclerosis (plaque buildup).
- Lp(a) (Lipoprotein(a)): Evaluates your genetic risk of cardiovascular disease and measures a genetically determined type of "sticky" bad cholesterol. It is not included in standard cholesterol panels. High levels of Lp(a) are strongly linked to premature coronary artery disease, stroke, and arterial blockage.
- Lp-PLA2 (Lipoprotein-associated phospholipase A2): Sometimes referred to as the PLAC test, it identifies inflammation specifically in the artery wall (vascular inflammation), signaling active atherosclerotic plaque that is at high risk of rupturing and causing heart attacks or strokes.
- NMR LipoProfile: Uses NMR technology to directly count the number of LDL particles (LDL-P) and their size, providing a more accurate risk assessment than traditional cholesterol tests. It often includes an insulin resistance score (LP-IR).
Together, these advanced panels provide a deeper understanding of cardiovascular and metabolic health than traditional cholesterol tests. By identifying hidden risk earlier, patients are empowered with clearer answers, earlier detection, and more informed decisions for long-term wellness.
Who Should Consider This Test?
It is recommended for individuals with risk factors such as:
- Family history of cardiovascular disease (CVD)
- History of hypertension or metabolic syndrome
- LDL cholesterol levels or triglycerides remains high despite medication
- Unexplained or low-risk profile, but still suffers from heart disease or at high risk
- Overweight or obese (BMI >25 or specific waist circumference)
- PCOS or sedentary lifestyle
These panels are used to catch issues early, allowing for preventive interventions like lifestyle changes or medication to avoid diabetes or heart attacks.
Complete Your Heart Health Profile
Advanced blood testing provides a clearer, more comprehensive understanding of your health helping identify risk earlier, refine treatment strategies, and support truly preventative care. By looking beyond traditional markers, it empowers both patients and providers to make more informed decisions with confidence.
At CardioNow, these advanced diagnostics are readily available as part of a proactive approach to heart and metabolic health. Contact us and receive clear answers that support meaningful health decisions and peace of mind.
